Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: Mature results of the Spanish Lung Cancer Group 0008 study

Lung Cancer ◽  
2013 ◽  
Vol 81 (1) ◽  
pp. 84-90 ◽  
Author(s):  
Pilar Garrido ◽  
Rafael Rosell ◽  
Antonio Arellano ◽  
Francisco Andreu ◽  
Manuel Dómine ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Stage Iii ◽  
Consolidation Chemotherapy ◽  
Cancer Group ◽  
Randomized Phase Ii ◽  
Concomitant Chemoradiation ◽  
Stage Iii Nsclc ◽  
Nsclc Patients

scholarly journals MA05.07 Dose Escalated Chemo-RT to 84 Gy in Stage III NSCLC Appears Excessively Toxic: Results from a Randomized Phase II Trial

2018 ◽  
Vol 13 (10) ◽  
pp. S373
Author(s):  
J. Nyman ◽  
S. Bergström ◽  
H. Björkestrand ◽  
A. Svärd ◽  
S. Ekman ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Stage Iii ◽  
Randomized Phase Ii ◽  
Stage Iii Nsclc

scholarly journals P2.02-027 A Randomized Phase II Trial of S-1 plus Cisplatin or Docetaxel plus Cisplatin with Concurrent Thoracic Radiotherapy for Stage III NSCLC: TORG1018

2017 ◽  
Vol 12 (1) ◽  
pp. S863
Author(s):  
Kazuhiko Yamada ◽  
Tsuneo Shimokawa ◽  
Hiroaki Okamoto ◽  
Hiroshi Tanaka ◽  
Kaoru Kubota ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Stage Iii ◽  
Thoracic Radiotherapy ◽  
Randomized Phase Ii ◽  
Stage Iii Nsclc
Sign in / Sign up

Export Citation Format

Share Document